Dr. Alberto Portone holds a degree in Medical Biotechnologies and Nanobiotechnologies and a PhD in Physics and Nanosciences. His scientific career has been distinguished by a strongly multidisciplinary approach, integrating micro- and nanofabrication, advanced materials engineering, 3D printing, and biofabrication technologies for applications spanning optics, biology, and biomedical sciences.
In the early stages of his career, he focused on nanotechnology-based strategies for the fabrication of patterned and fibrous scaffolds designed to guide cell adhesion, morphology, and stem cell differentiation through precise nanoscale modifications. This work laid the foundation for the development of engineered microenvironments capable of modulating cellular behavior in a controlled manner.
He subsequently expanded his research toward the development of 3D-printed devices and bioprinted artificial tissues, including fibrotic, vascular, and skin models for advanced in vitro testing. His current research combines microfluidics and 3D bioprinting to engineer innovative organ-on-chip platforms. He is particularly engaged in the design of 3D tumor cell culture models, biomimetic hydrogels, and advanced biofabrication strategies aimed at investigating cell phenotype, migration, and behavior as functional readouts within physiologically relevant in vitro systems.
Dr. Alberto Portone holds a degree in Medical Biotechnologies and Nanobiotechnologies and a PhD in Physics and Nanosciences. His scientific career has been distinguished by a strongly multidisciplinary approach, integrating micro- and nanofabrication, advanced materials engineering, 3D printing, and biofabrication technologies for applications spanning optics, biology, and biomedical sciences.
In the early stages of his career, he focused on nanotechnology-based strategies for the fabrication of patterned and fibrous scaffolds designed to guide cell adhesion, morphology, and stem cell differentiation through precise nanoscale modifications. This work laid the foundation for the development of engineered microenvironments capable of modulating cellular behavior in a controlled manner.
He subsequently expanded his research toward the development of 3D-printed devices and bioprinted artificial tissues, including fibrotic, vascular, and skin models for advanced in vitro testing. His current research combines microfluidics and 3D bioprinting to engineer innovative organ-on-chip platforms. He is particularly engaged in the design of 3D tumor cell culture models, biomimetic hydrogels, and advanced biofabrication strategies aimed at investigating cell phenotype, migration, and behavior as functional readouts within physiologically relevant in vitro systems.